Back
Actinium Pharmaceuticals Vs. Cellectar Biosciences Industry Stock Comparison
Buy
53
ATNM
Actinium Pharmaceuticals
Last Price:
9.68
Seasonality Move:
-2.01%
Buy
70
CLRB
Cellectar Biosciences
Last Price:
3.16
Seasonality Move:
-0.86%
Buy
53
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.80. The Score for ATNM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Cellectar Biosciences (CLRB)
is a Buy
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $3.30. The Score for CLRB is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CLRB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing slight buying pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $3.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | 78855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.1 - 9.24) | Buy |
| Bollinger Bands (100): | (5.53 - 8.61) | Buy |
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 50.21 | Buy |
| Chaikin Money Flow: | -454397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.07 - 3.31) | Buy |
| Bollinger Bands (100): | (3.1 - 3.86) | Sell |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.31 | Buy |
| 20-day SMA: | 8.37 | Buy |
| 50-day SMA: | 8.18 | Buy |
| 200-day SMA: | 6.36 | Buy |
| 8-day EMA: | 9.38 | Buy |
| 20-day EMA: | 8.78 | Buy |
| 50-day EMA: | 8.14 | Buy |
| 200-day EMA: | 7.12 | Buy |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.22 | Buy |
| 20-day SMA: | 3.19 | Buy |
| 50-day SMA: | 3.47 | Sell |
| 200-day SMA: | 2.88 | Buy |
| 8-day EMA: | 3.25 | Buy |
| 20-day EMA: | 3.26 | Buy |
| 50-day EMA: | 3.37 | Sell |
| 200-day EMA: | 3.04 | Buy |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $1.19 per share, and an increase next year of $0.88 per share.
Actinium Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cellectar Biosciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||